What is the role of biomarkers in the diagnosis of minimal-change disease (MCD)?

Updated: Jan 05, 2021
  • Author: Abeera Mansur, MD; Chief Editor: Vecihi Batuman, MD, FASN  more...
  • Print

Increasing interest centers on the possibility of using urinary levels of CD80 as a biomarker in MCD (see Pathophysiology and Prognosis). Elevated levels may help differentiate MCD from FSGS [7] and predict responsiveness to corticosteroids. [16, 17]

Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!